HPLC Method for Analysis of Defactinib on Primesep B Column
https://sielc.com/hplc-separation-of-defactinChromatogram
Description
· High Performance Liquid Chromatography (HPLC) Method for Analysis of Defactinib
Defactinib is a focal adhesion kinase (FAK) inhibitor with the chemical formula C 20 H 21 F 3 N 8 O 3 S . It was developed by Pfizer as potential treatment for solid tumors. You can find detailed UV spectra of Defactinib and information about its various lambda maxima by visiting the following link.
Defactinib can be retained and analyzed using the Primesep B stationary phase column. The analysis utilizes an isocratic method with a simple mobile phase consisting of water and acetonitrile (MeCN) with a sulfuric acid buffer. Detection is performed using UV.
Method Parameters
| Mobile Phase | Gradient MeCN/H2O – 30/70% – 70/30%, 10 min |
|---|---|
| Buffer | H2SO4 – 0.2% |
| Flow Rate | 1.0 ml/m |
| Detection | UV 200 nm |
| Class of Compounds | Inhibitor |
| Analyzing Compounds | Defactinib |
HPLC Column Used
Primesep B, 4.6 x 150 mm, 5 µm, 100 A, dual ended